Birmingham, West Midlands -- (SBWIRE) -- 11/29/2013 -- Value Penny Stocks issues special report on Danone SA (ADR) (OTCMKTS:DANOY), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Ligand Pharmaceuticals Inc. (NASDAQ:LGND), AT&T Inc. (NYSE:T).
Danone SA (ADR) (OTCMKTS:DANOY) opened its last trade at the price of $14.59. Its closing price was $14.61 after losing 0.27% for the day. The company traded with the total volume of 1.56 million shares, while its average trading volume remained 1.26 million shares. The beta of this stock stands at 0.80. Danone produces and distributes food and beverage products. The company’s Fresh Dairy Products division offers yogurts, fermented dairy products, and other specialty fresh dairy products under the Activia, Actimel, Danonino, Fruchtswerge, Danoninho, Petit Gervais, Danimals, Serenito, Milkuat, Danacol, Densia, Oikos, Danette, Fantasia, Vitalinea, Taillefine, and Ser brands.
Has DANOY Found The Bottom and Ready To Move Up? Find Out Here
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) percentage change surged 0.26% to close at $3.79 with the total traded volume of 1.50 million shares, along with average volume of 1.45 million shares. The 52 week range of the stock remained $0.73 - $3.85, while its day lowest price was $3.68. The share price hit the day highest price of $3.85. Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products.
For How Long CHTP’s Gloss will Attract Investors? Find out via this report
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) traded on volume of 2.91 million shares in the last session against average volume of 355,264.00 shares. The company started its trading session with the price of $57.25 and closed at $56.97 by scoring -1.35%. Ligand Pharmaceuticals Incorporated, a biotechnology company, engages in the acquisition and development of royalty revenue generating assets in the United States. The company’s assets include PROMACTA, an oral thrombopoietin receptor agonist therapy for the treatment of adult patients with chronic immune thrombocytopenic purpura.
Why Should Investors Buy LGND After the Recent Fall? Just Go Here and Find Out
AT&T Inc. (NYSE:T) started its last trading session with the price of $35.29 and closed at $35.41 by scoring 0.37%. The stock traded with total volume of 11.47 million shares, while the average trading volume remained 23.36 million shares. The beta value of this stock stands at 0.48. Day range for the stock was $35.19 - $35.42. AT&T Inc. provides telecommunications services to consumers, businesses, and other providers in the United States and internationally. The company operates in three segments: Wireless, Wireline, and Other.
Why Should Investors Buy T After The Recent Gain? Just Go Here and Find Out
SAbout Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)